Director sold ~$1.2M of Regeneron Pharmaceuticals
Scheduled in advanceLoading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director exercised or converted 1,500 REGN derivative securities
Traded Jan 7, 2026 · Filed Jan 8, 2026
- 1,500
- Shares · @ $374.12
Why it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jan 7, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jan 8, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001683607-26-000008
